HOMA-IR
OtherWhat is HOMA-IR?
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated index used to estimate insulin resistance and beta-cell function from fasting blood glucose and fasting insulin levels. The formula—fasting glucose (mg/dL) × fasting insulin (µU/mL) ÷ 405—provides a simple, cost-effective surrogate measure of insulin sensitivity that correlates well with the gold-standard hyperinsulinemic-euglycemic clamp technique. Developed by Matthews et al. in 1985, HOMA-IR has become one of the most widely used research and clinical tools for assessing insulin resistance.
Insulin resistance occurs when cells in the liver, muscle, and fat tissue respond poorly to insulin's signal to take up glucose from the blood. To compensate, the pancreas produces more insulin, maintaining normal blood sugar at the cost of chronically elevated insulin levels (hyperinsulinemia). HOMA-IR captures this relationship: in an insulin-resistant individual, both fasting glucose and fasting insulin are higher than expected, yielding an elevated HOMA-IR score. This metabolic state precedes type 2 diabetes by years to decades and is central to metabolic syndrome, non-alcoholic fatty liver disease, polycystic ovary syndrome, and cardiovascular disease.
Why It Matters
HOMA-IR detects insulin resistance years before blood sugar levels become abnormal, providing a critical early warning window for metabolic disease prevention. By the time fasting glucose or HbA1c reaches the prediabetic range, significant beta-cell dysfunction has already occurred. HOMA-IR identifies the compensatory hyperinsulinemia that precedes glucose elevation, allowing earlier lifestyle and therapeutic interventions. Studies show that elevated HOMA-IR independently predicts the development of type 2 diabetes, cardiovascular events, non-alcoholic fatty liver disease, and certain cancers—even in individuals with normal glucose tolerance tests.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Optimal | <1.0 | |
| Normal | 1.0–1.9 | |
| Early insulin resistance | 2.0–2.9 | |
| Significant insulin resistance | ≥3.0 |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High HOMA-IR Levels Mean
Common Causes
- Metabolic syndrome
- Obesity, especially visceral (abdominal) obesity
- Physical inactivity
- Polycystic ovary syndrome (PCOS)
- Non-alcoholic fatty liver disease (NAFLD)
- Chronic stress and poor sleep
- High-sugar, high-refined-carbohydrate diet
- Medications (corticosteroids, certain antipsychotics)
- Genetic predisposition
Possible Symptoms
- Abdominal weight gain resistant to diet
- Fatigue, especially after meals
- Brain fog and difficulty concentrating
- Sugar and carbohydrate cravings
- Skin tags and acanthosis nigricans (darkened skin folds)
- High triglycerides and low HDL cholesterol
- High blood pressure
- Often asymptomatic in early stages
What to do: Lifestyle modification is the cornerstone of treatment. Regular exercise (150+ minutes/week of moderate activity, including resistance training) dramatically improves insulin sensitivity. Reduce refined carbohydrates and added sugars; adopt a Mediterranean or whole-food diet. Weight loss of 5–10% significantly reduces HOMA-IR. Prioritize 7–9 hours of quality sleep. Manage stress through mindfulness or other strategies. For PCOS, metformin may be indicated. Consider consultation with an endocrinologist if HOMA-IR remains elevated despite lifestyle changes.
What Low HOMA-IR Levels Mean
Common Causes
- Normal, healthy insulin sensitivity
- Active lifestyle with regular exercise
- Low body fat percentage
- Healthy diet
- In very low values: possible beta-cell dysfunction (not enough insulin produced)
Possible Symptoms
- No symptoms—low HOMA-IR indicates good insulin sensitivity
- If very low with high glucose: may indicate insulin deficiency (type 1 diabetes risk)
What to do: A low HOMA-IR is generally desirable and indicates healthy insulin sensitivity. Continue maintaining healthy lifestyle habits. If HOMA-IR is very low but fasting glucose is elevated, this paradoxically may indicate inadequate insulin production (beta-cell failure) rather than good insulin sensitivity—further evaluation with C-peptide and diabetes antibody testing may be warranted.
When Is HOMA-IR Testing Recommended?
- When metabolic syndrome is suspected
- In patients with central obesity and metabolic risk factors
- For women with PCOS to assess metabolic component
- To evaluate non-alcoholic fatty liver disease
- When screening for prediabetes in high-risk individuals
- To monitor response to lifestyle interventions or medications
Frequently Asked Questions
Related Biomarkers
Want your HOMA-IR levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.